Momenta Pharmaceuticals, Inc.
MNTA
MNTA was delisted on the 30th of September, 2020.
143 hedge funds and large institutions have $502M invested in Momenta Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 53 reducing their positions, and 21 closing their positions.
3% less funds holding
Funds holding: 148 → 143 (-5)
6% less capital invested
Capital invested by funds: $536M → $502M (-$33.9M)
21% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 53
24% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 21
38% less call options, than puts
Call options by funds: $3.38M | Put options by funds: $5.42M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$8.14M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$5.25M |
| 3 |
Morgan Stanley
New York
|
+$4.73M |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$4.54M |
| 5 |
VAM
Visium Asset Management
New York
|
+$3.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$7.98M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$6.12M |
| 3 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$4.23M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$3.74M |
| 5 |
Axa
Paris,
France
|
-$2.27M |
MNTA Hedge Fund Activity: Q3 2014 in Review
143 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q3 2014, worth a combined $502M — down 6.3% from $536M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of MNTA and 16 opened new positions — a net loss of 5 holders — while 53 trimmed existing stakes and 42 added.
The largest buyer was Tekla Capital Management, adding an estimated $8.14M. The largest seller was EverPoint Asset Management, cutting an estimated $7.98M.
- 143 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q3 2014, down from 148 in Q2 2014.
- Funds reported $502M of Momenta Pharmaceuticals, Inc. stock for Q3 2014, down 6.3% quarter-over-quarter.
- 16 funds opened new Momenta Pharmaceuticals, Inc. positions in Q3 2014 and 21 closed out, a net change of -5 holders.
- The largest Momenta Pharmaceuticals, Inc. buyer in Q3 2014 was Tekla Capital Management, an estimated $8.14M added.
- The largest Momenta Pharmaceuticals, Inc. seller in Q3 2014 was EverPoint Asset Management, an estimated $7.98M sold.
Based on aggregated 13F filings for Q3 2014.